Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 34.28M P/E - EPS this Y 59.30% Ern Qtrly Grth -
Income -124.65M Forward P/E -0.92 EPS next Y 39.90% 50D Avg Chg 15.00%
Sales 60.26M PEG - EPS past 5Y - 200D Avg Chg -37.00%
Dividend N/A Price/Book 0.44 EPS next 5Y - 52W High Chg -88.00%
Recommedations 2.70 Quick Ratio 3.81 Shares Outstanding 6.03M 52W Low Chg 55.00%
Insider Own 16.89% ROA -28.31% Shares Float 4.13M Beta 0.57
Inst Own 52.18% ROE -118.52% Shares Shorted/Prior 13.83K/30.61K Price 0.29
Gross Margin 36.71% Profit Margin -206.85% Avg. Volume 443,666 Target Price 13.83
Oper. Margin -60.40% Earnings Date May 13 Volume 463,264 Change 6.76%
About Science 37 Holdings, Inc.

Science 37 Holdings, Inc. engages in patient-centric clinical trial activities in North Carolina. Its platform enables modern and digital approaches to clinical research, including the patient and trial investigators, nurses, coordinators, and sponsors, standardize evidence generation, and harmonize data. The company's platform also provides specialized networks of patient communities, telemedicine investigators, mobile nurses, remote coordinators, and connected devices for orchestrating clinical trials; and extensive configuration to support virtually any phase of clinical study and therapeutic area. In addition, the company licenses its proprietary hosted technology platform to various life science institutions. It serves large and mid-sized pharmaceutical companies, contract research organizations, academic institutions, and biotech companies. Science 37 Holdings, Inc. was founded in 2014 and is based in Research Triangle Park, North Carolina. As of March 11, 2024, Science 37 Holdings, Inc. operates as a subsidiary of eMed, LLC.

SNCE Chatroom

User Image Stock_Titan Posted - 2 months ago

$SNCE Science 37 Earns Frost & Sullivan’s 2024 Global Company of the Year Award for Decentralized Clinical Trials https://www.stocktitan.net/news/SNCE/science-37-earns-frost-sullivan-s-2024-global-company-of-the-year-0dwxhp3dm8pu.html

User Image NVDAMillionaire Posted - 3 months ago

$SNCE Science 37 Holdings, Inc. (NASDAQ:SNCE): Pioneering Patient-Centric Clinical Trials Amidst Operational Challenges http://beyondspx.com/2024/08/05/science-37-holdings-inc-nasdaqsnce-pioneering-patient-centric-clinical-trials-amidst-operational-challenges/

User Image Stock_Titan Posted - 3 months ago

$SNCE Science 37 Unveils New Corporate Headquarters in Research Triangle Park, NC https://www.stocktitan.net/news/SNCE/science-37-unveils-new-corporate-headquarters-in-research-triangle-ishz7aq3lutc.html

User Image Stock_Titan Posted - 4 months ago

$SNCE Science 37 Enrolls 42% of Trial Cohort in 8 Weeks https://www.stocktitan.net/news/SNCE/science-37-enrolls-42-of-trial-cohort-in-8-pes8f9k98qih.html

User Image Stock_Titan Posted - 06/27/24

$SNCE Science 37 Quickly Impacts Performance in Under-Enrolling Clinical Trials https://www.stocktitan.net/news/SNCE/science-37-quickly-impacts-performance-in-under-enrolling-clinical-unzt8nv4dy9l.html

User Image faf314 Posted - 06/25/24

$SNCE dead money for almost a year ......... You're not good at this game

User Image Stock_Titan Posted - 5 months ago

$SNCE CORRECTION-- Science 37 Surpasses Enrollment Goals, Accelerates Phase 2 Rare Disease Clinical Trial https://www.stocktitan.net/news/SNCE/correction-science-37-surpasses-enrollment-goals-accelerates-phase-2-f4s1m4juhm0z.html

User Image Stock_Titan Posted - 5 months ago

$SNCE Science 37 Surpasses Enrollment Goals, Accelerates Phase 2 Rare Disease Clinical Trial https://www.stocktitan.net/news/SNCE/science-37-surpasses-enrollment-goals-accelerates-phase-2-rare-hglpnch2scbv.html

User Image Stock_Titan Posted - 6 months ago

$SNCE Science 37 Metasite™ Undergoes Successful FDA Inspection, Marking Major Milestone in Virtual Site Quality Assurance and Compliance https://www.stocktitan.net/news/SNCE/science-37-metasite-undergoes-successful-fda-inspection-marking-knlg1xki9y6x.html

User Image Stock_Titan Posted - 6 months ago

$SNCE Science 37 Wins 2024 MedTech Breakthrough Award for “Clinical Efficiency Innovation” https://www.stocktitan.net/news/SNCE/science-37-wins-2024-med-tech-breakthrough-award-for-clinical-k4vtov96huwv.html

User Image Stock_Titan Posted - 6 months ago

$SNCE Science 37 Delivers 22x Faster Enrollment than Traditional Methods in Phase 3 Asthma Clinical Trial https://www.stocktitan.net/news/SNCE/science-37-delivers-22x-faster-enrollment-than-traditional-methods-6cmj8w5t32jv.html

User Image Stock_Titan Posted - 7 months ago

$SNCE Science 37 Provides Fully Consented Patients to Sites to Supplement Enrollment https://www.stocktitan.net/news/SNCE/science-37-provides-fully-consented-patients-to-sites-to-supplement-f2z3zmj9a5qi.html

User Image parabolicrunners Posted - 8 months ago

$SNCE

User Image Stock_Titan Posted - 8 months ago

$SNCE eMed completes tender offer for all outstanding shares of Science 37 https://www.stocktitan.net/news/SNCE/e-med-completes-tender-offer-for-all-outstanding-shares-of-science-4zggs1e8snag.html

User Image SM095 Posted - 8 months ago

Pending news list: $LMFA, $CUROQ,$SNCE, $SOVO

User Image Mergerbrief Posted - 8 months ago

$SNCE eMed, LLC - Tender Offer(Midnight) expires mergerbrief.com

User Image DonCorleone77 Posted - 9 months ago

$SNCE Tender offer for Science 37 by eMed commences eMed's wholly-owned subsidiary Marlin Merger Sub has commenced a cash tender offer to purchase all the outstanding shares of common stock, par value $0.0001 per share, of Science 37 for a price of $5.75 per share. A successful consummation of the tender offer will be followed by a merger to acquire any untendered shares of Science 37 for the same price payable in the tender offer. The offer will expire at 12:00 midnight, NYC time, at the end of the day of March 11, unless extended. The offer is subject to customary closing conditions, including the tender of at least a majority in voting power of the shares of Science 37 common stock then issued and outstanding and is not subject to a financing condition.

User Image parabolicrunners Posted - 9 months ago

$SNCE

User Image Stock_Titan Posted - 9 months ago

$SNCE eMed commences tender offer for Science 37 https://www.stocktitan.net/news/SNCE/e-med-commences-tender-offer-for-science-6a3nye41gipb.html

User Image TickerDD_com Posted - 9 months ago

From 2/2/2024, looking back across 22 Month-Ends for SNCE, Percentage Change of Average Monthly Price had Equal (50%) while Percentage Change of Average Monthly Volume had All Positives (100%) $SNCE #SNCE #SNCEStock #TickerDD #SNCEPrice https://www.youtube.com/watch?v=0uQVTCXvO1E

User Image kelly1874 Posted - 9 months ago

$IFBD that was a sweet move; so clean & quick with no fuss. Reminds me of what happened to $SNCE on March 17. Similar sudden spike just before closing. Congrats to all of you who banked on this one; wish I could have joined you but had already shut it down!

User Image FooTie402 Posted - 01/31/24

$SNCE What a shit deal long term share holders got here

User Image ikkydiphoenix Posted - 01/29/24

$SNCE the deal is so bad that i'm surprised they refused my 0.0000001$ offer..

User Image swingingtech Posted - 01/29/24

$QQQ $SNCE $SOFI $CDLX https://wallstreetwaves.com/crude-oil-down-over-1-science-37-holdings-shares-spike-higher/

User Image tradingtwenty Posted - 01/29/24

$SNCE has trended 7 times in the past 24 hours (based on 5 minute intervals). Latest article on Jan 29, 2024 07:30 AM: Science 37 to be Acquired by eMed, Expanding Access to Patients and Accelerating Enrollment Link: https://tradingtwenty.com/news/336929/science-37-to-be-acquired-by-emed-expanding-access-to-patients-and-accelerating-enrollment

User Image hidjay01 Posted - 01/29/24

$SNCE buy more ! target 30 !

User Image hidjay01 Posted - 01/29/24

User Image MasterOfMyDomains Posted - 01/29/24

$SNCE stupid

User Image AKnewMann Posted - 01/29/24

$SNCE I take it this deal will have to be approved by shareholders

User Image AKnewMann Posted - 01/29/24

$SNCE $5.75 pps acquisition is robbery

Analyst Ratings
Baird Neutral Jan 30, 24
Craig-Hallum Hold Jan 29, 24